Tag: NT-814

Bayer to acquire KaNDy Therapeutics to add menopause drug candidate

pharmanewsdaily- August 11, 2020 0

Bayer has agreed to acquire KaNDy Therapeutics, a UK clinical-stage biotech company, in a deal worth up to $900 million, in a move to grow ... Read More